A novel in vivo platform to study and target undruggable Ewing onco-chimera.

Project Information

EwiSarc

Grant agreement ID: 749795

DOI 10.3030/749795

Project closed

EC signature date 17 March 2017

Start date 1 May 2017

End date 30 April 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 180 277,20

EU contribution € 180 277,20

Coordinated by

UNIVERSITA DEGLI STUDI DI TRENTO
Italy